Cargando…
The Assessment of Anti-Melanoma Potential of Tigecycline—Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells
High mortality, aggressiveness, and the relatively low effectiveness of therapy make melanoma the most dangerous of skin cancers. Previously published studies presented the promising therapeutic potential of minocycline, doxycycline, and chlortetracycline on melanoma cells. This study aimed to asses...
Autores principales: | Rok, Jakub, Kowalska, Justyna, Rzepka, Zuzanna, Stencel, Dominika, Skorek, Anna, Banach, Klaudia, Wrześniok, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296940/ https://www.ncbi.nlm.nih.gov/pubmed/37371034 http://dx.doi.org/10.3390/cells12121564 |
Ejemplares similares
-
The Anticancer Potential of Doxycycline and Minocycline—A Comparative Study on Amelanotic Melanoma Cell Lines
por: Rok, Jakub, et al.
Publicado: (2022) -
The Assessment of the Phototoxic Action of Chlortetracycline and Doxycycline as a Potential Treatment of Melanotic Melanoma—Biochemical and Molecular Studies on COLO 829 and G-361 Cell Lines
por: Rok, Jakub, et al.
Publicado: (2023) -
Ketoprofen Combined with UVA Irradiation Exerts Higher Selectivity in the Mode of Action against Melanotic Melanoma Cells than against Normal Human Melanocytes
por: Banach, Klaudia, et al.
Publicado: (2021) -
Cellular and Molecular Aspects of Anti-Melanoma Effect of Minocycline—A Study of Cytotoxicity and Apoptosis on Human Melanotic Melanoma Cells
por: Rok, Jakub, et al.
Publicado: (2020) -
Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes
por: Respondek, Michalina, et al.
Publicado: (2019)